m6A-FORM: New Foundation Model Improves Prediction of RNA Methylation Sites
Researchers have developed m6A-FORM, a transformer-based foundation model pretrained on roughly 22 million sequences from 143 human MeRIP-seq studies to predict N6-methyladenosine (m6A) modification sites in RNA. The model addresses longstanding limitations of existing predictors, which rely on adenosine-centered approaches prone to false positives and computational inefficiency. By enabling more accurate and faster identification of m6A sites across human tissues, the work could advance understanding of RNA regulation and mRNA degradation.
m6A-FORM is a new foundation model for predicting N6-methyladenosine (m6A), the most common internal chemical modification found in eukaryotic messenger RNA. The model was pretrained on approximately 22 million peak-derived sequences drawn from 143 human MeRIP-seq studies, using methylation-enriched genomic regions as prior information rather than the adenosine-centered formulations used by most existing tools. After fine-tuning on high-confidence single-nucleotide m6A annotations from two reference datasets—m6A-Atlas v2.0 and GLORI—the resulting model, m6A-FORM-sites, achieved a PR-AUC of 0.635 and ROC-AUC of 0.988, improving precision-recall performance by at least 0.14 over competing methods while also enabling faster inference. Beyond site prediction, task-specific adaptations allow the model to predict binding sites for 19 m6A-associated regulatory proteins and to identify YTHDF2-bound m6A sites linked to mRNA degradation. Applying the model across 67 datasets from 24 human tissues revealed 19,631 tissue-conserved m6A sites with distinct biological signatures related to localization, clustering, RNA-binding protein interactions, and mRNA decay.
What's missing
As a preprint posted to arXiv, this work has not yet undergone formal peer review, so its claims of state-of-the-art performance have not been independently validated. The study relies on existing benchmark datasets (m6A-Atlas v2.0 and GLORI) for fine-tuning, and performance may vary with different annotation sources or sequencing protocols. Generalizability beyond human tissues to other species or disease contexts is not addressed. The biological significance of the 19,631 tissue-conserved sites identified remains to be experimentally validated.
What different sources said
- arXiv q-bioCenter
m6A-FORM: A Foundation Model for Decoding N6-methyladenosine Biology
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.